Compare INSE & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INSE | OABI |
|---|---|---|
| Founded | 2002 | 2012 |
| Country | United States | United States |
| Employees | N/A | 114 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 230.5M | 253.4M |
| IPO Year | 2014 | N/A |
| Metric | INSE | OABI |
|---|---|---|
| Price | $7.14 | $1.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $13.25 | $6.67 |
| AVG Volume (30 Days) | 54.7K | ★ 284.4K |
| Earning Date | 06-19-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 753.85 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $199,800,000.00 | N/A |
| Revenue This Year | $4.09 | $74.84 |
| Revenue Next Year | N/A | $40.54 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 30.25 | N/A |
| 52 Week Low | $6.51 | $1.22 |
| 52 Week High | $10.29 | $3.33 |
| Indicator | INSE | OABI |
|---|---|---|
| Relative Strength Index (RSI) | 33.32 | 60.03 |
| Support Level | $6.84 | $1.85 |
| Resistance Level | $9.69 | $2.15 |
| Average True Range (ATR) | 0.44 | 0.10 |
| MACD | -0.03 | 0.03 |
| Stochastic Oscillator | 5.37 | 70.51 |
Inspired Entertainment Inc is a gaming technology company based in the United States. Its core business involves the development of Virtual Sports and Server-Based Gaming systems with associated terminals and digital content to regulate betting, gaming, and lottery operators around the world. It operates through four segments, namely Gaming, Virtual Sports, Interactive, and Leisure. The company generates maximum revenue from the Gaming segment. Its Gaming segment supplies gaming terminals as well as gaming software and games for the terminals provided to betting offices, casinos, gaming halls, and high street adult gaming centers. Geographically, it derives a majority of revenue from the UK.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.